نتایج جستجو برای: c did not change significantly p005finally

تعداد نتایج: 4523649  

Journal: :Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2012
Johan Mårtensson Claes-Roland Martling Anders Oldner Max Bell

BACKGROUND Cystatin C is a marker of acute kidney injury (AKI). However, systemic inflammation associated with sepsis, a common AKI-trigger, may affect cystatin C. We studied the impact of sepsis on cystatin C levels in plasma. Furthermore, we investigated whether the presence of sepsis affects the predictive properties of cystatin C. METHODS Three hundred and twenty-seven intensive care unit...

Faramarz Ganjian, Fariba Ahmadi, Jafar Forghanizadeh, Mohammad Kheirkhah, Mohammadreza Sadeghian,

28 patients with classical / definite RA entered to a prospective open study evaluating efficacy and side effects of Auranofin. 21 patients completed 6 months of therapy with 6 mg Auranofin daily. Parameters of disease activity including Joint Tenderness Score, Joint Swelling Score, Walking Time and duration of Morning Stiffness improved significantly after 6 months (p<0.001). Grip strength, Su...

Journal: :iranian journal of pharmacology and therapeutics 0
sanjib khargharia

the blood biochemical parameters were investigated in a yak (bos grunniens l) after intravenous administration of 5 mg/kg enrofloxacin. blood samples were collected from the jugular vein daily for 5 days after the drug administration. heparinized bloods were collected for mean corpuscular volume (mcv), erythrocyte sedimentation rate (esr), hemoglubin (hb) estimation and serum was collected for ...

Journal: :journal of research in medical sciences 0
behrooz heydari hossein khalili mohammad?taghi beigmohammadi alireza abdollahi iman karimzadeh

background: the most common clinical indication of aminoglycosides (ag) is the treatment of serious gram?negative infections.the aim of this study was to evaluate plausible effects of atorvastatin on the biomarkers of acute kidney injury (aki) in patients receiving amikacin. materials and methods: in this double?blinded randomized clinical trial, fifty patients (25 in each group) receiving amik...

2015
Timothy R. Morgan Kathryn Osann Teodoro Bottiglieri Neville Pimstone John C. Hoefs Ke-Qin Hu Tarek Hassanein Thomas D. Boyer Lorene Kong Wen-Pin Chen Ellen Richmond Rachel Gonzalez Luz M. Rodriguez Frank L. Meyskens

In animal models of hepatocellular carcinoma (HCC), deficiency of S-adenosylmethionine (SAMe) increased the risk of HCC whereas administration of SAMe reduced HCC. The aim of this trial was to determine whether oral SAMe administration to patients with hepatitis C cirrhosis would decrease serum a-fetoprotein (AFP) level, a biomarker of HCC risk in hepatitis C. This was a prospective, randomized...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید